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a b s t r a c t
Poxviruses differ from most DNA viruses by replicating entirely within the cytoplasm. The ﬁrst
discernible viral structures are crescents and spherical immature virions containing a single lipoprotein
membrane bilayer with an external honeycomb lattice. Because this viral membrane displays no obvious
continuity with a cellular organelle, a de novo origin was suggested. Nevertheless, transient connections
between viral and cellular membranes could be difﬁcult to resolve. Despite the absence of direct
evidence, the intermediate compartment (ERGIC) between the endoplasmic reticulum (ER) and Golgi
apparatus and the ER itself were considered possible sources of crescent membranes. A break-through in
understanding poxvirus membrane biogenesis has come from recent studies of the abortive replication
of several vaccinia virus null mutants. Novel images showing continuity between viral crescents and the
ER and the accumulation of immature virions in the expanded ER lumen provide the ﬁrst direct evidence
for a cellular origin of this poxvirus membrane.
Published by Elsevier Inc.
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Brief introduction to poxviruses
Poxviruses are large DNA viruses that infect vertebrates and
invertebrates and include species that cause severe human disease
(e.g. smallpox and monkeypox) and others that serve beneﬁcial roles
as vectors for vaccines against unrelated infectious agents (Damon,
2013; Moss, 2013a). The ability to reproduce entirely within the
cytoplasm is a deﬁning characteristic of the poxvirus family and
depends on viral proteins for replication (Moss, 2013b) and tran-
scription (Broyles and Knutson, 2010) of the large DNA genome.
Approximately 100 genes, conserved in all chordopoxviruses, are
required for reproduction in cultured cells (Upton et al., 2003; Xu et
al., 2014); a similar number of less well conserved genes are
important for optimal infection of animals (Haller et al., 2014;
Smith et al., 2013). The cytoplasmic sites of viral DNA synthesis
expand into factories where the intermediate and late stages of
transcription and translation occur (Katsafanas and Moss, 2007).
Crescent membranes appear within the factories and enlarge to
form spherical immature virions (IVs) that condense into dense
brick-shaped mature virions (MVs) (Gaylord and Melnick, 1953;
Morgan et al., 1954; Morgan and Wyckoff, 1950). Depending on the
poxvirus genus, MVs may be enclosed by an additional membrane
derived from the trans-Golgi, endosomal cisternae or plasma mem-
brane (Boulanger et al., 2000; Hiller andWeber, 1985; Schmelz et al.,
1994; Tooze et al., 1993) to form wrapped virions (WVs) and
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transported to the cell periphery and exocytosed as extracellular
enveloped virions (EVs) (Fig. 1).
The structure and origin of the poxviral membrane delimiting
crescents and IVs have intrigued virologists for more than half a
century. The inability to discern connections between the viral
membranes and cellular organelles (Fig. 2) led to the idea that viral
membranes form de novo (Dales and Mosbach, 1968). However, the
connections could be transient and an origin from cell membranes
comprising the intermediate compartment (ERGIC) between the
endoplasmic reticulum (ER) and Golgi apparatus (Sodeik and
Krijnse-Locker, 2002) and from the ER itself (Husain et al., 2006)
have been considered. This review focuses on recent studies that
provide evidence for the formation of the crescent and IV membrane
from the ER. Although the main features of morphogenesis are
similar in all poxviruses, most research has been carried out with
vaccinia virus (VACV). Several broad reviews of poxvirus structure
and morphogenesis are available (Condit et al., 2006; Liu et al., 2014;
Moss, 2013a; Roberts and Smith, 2008).
One membrane or two?
Electron micrographs from the 1950s describe clusters of sphe-
rical IVs and dense brick-shaped MVs (Gaylord and Melnick, 1953;
Morgan et al., 1954; Morgan andWyckoff, 1950). In some images, the
IVs appear to have a double membrane with an outer dense layer of
4 to 6 nm and an inner of about the same thickness (Higashi et al.,
1960). In other images (Dales and Mosbach, 1968) there appears to
be a single membrane sheet coated with dense spicules, rather than
two lipid membranes. The latter interpretation is supported by
studies with the drug rifampicin, which prevents the formation of
the spicule layer and provides clear images of a single membrane
bilayer (Grimley et al., 1970; Moss et al., 1969; Nagayama et al., 1970).
Nevertheless, the concept of a double-membrane was revived in a
series of subsequent publications that posit two membranes so
tightly apposed as to give the illusion of a single membrane
(Krijnse-Locker et al., 1996; Risco et al., 2002; Salmons et al., 1997;
Sodeik et al., 1993, 1994, 1995). However, careful measurements of
the thickness of the IV membrane (Hollinshead et al., 1999) and
freeze-fracture (Heuser, 2005) fully support the prior single lipid
membrane model and deep-etch and immunoelectron microscopy
demonstrate that the “spicule layer” is a honeycomb lattice com-
prised of VACV D13 protein trimers external to the single membrane
(Heuser, 2005; Szajner et al., 2005). The controversy ended when
proponents of the double-membrane and others reported electron
tomography images conﬁrming a single membrane (Chichon et al.,
2009; Chlanda et al., 2009).
De novo membrane biogenesis or acquisition from host
membranes?
Failure to detect continuity between the crescent membrane and
cellular organelles led to the conclusion that the open-ended sheets
are formed de novo (Dales and Mosbach, 1968). Although seemingly
a heretical notion, in view of the formation of all known membranes
from pre-existing ones, a de novo viral origin could not be dismissed
out of hand since poxviruses are complex and encode proteins for
many other functions including genome replication, transcription
and disulﬁde bond formation (Moss, 2013a). Moreover, no viral
protein components of the IV or MV are known to have signal
peptides or to be glycosylated, which are signatures of trafﬁcking
through the secretory pathway of the cell. However, immunogold
electron microscopic studies localized some VACV membrane pro-
teins to the rough ER and the ERGIC, suggesting that the latter might
contribute to the formation of the viral membrane (Krijnse-Locker
et al., 1996; Rodríguez et al., 1996; Salmons et al., 1997; Sodeik et al.,
1995; Sodeik and Krijnse-Locker, 2002). Smooth ER membranes
labeled with protein disulﬁde isomerase (PDI) and viral proteins
have also been found in close proximity to crescents (Chlanda et al.,
2009; Husain et al., 2006). In addition, the association of VACV
membrane proteins with microsomes was demonstrated by in vitro
translation (Betakova et al., 1999a; Krijnse-Locker et al., 1996).
However, analysis of puriﬁed MVs failed to detect cellular membrane
proteins (Chung et al., 2006; Krauss et al., 2002; Resch et al., 2007)
and the above studies only provide circumstantial evidence for
participation of the ERGIC or ER in viral membrane formation.
Further studies were intended to discriminate functionally
between possible contributions of different cellular organelles to
viral membrane assembly. The fungal metabolite brefeldin A did
not prevent the formation of IVs and MVs, although wrapping of
the latter with Golgi membranes was impaired (Ulaeto et al.,
Fig. 1. Transmission electron microscopic image of a HeLa cell infected with VACV.
Abbreviations: MV, mature virion; IV, immature virion; WV, wrapped virion; EV,
extracellular enveloped virion; n, IV with nucleoid. Scale bar at bottom. Provided by
A. Weisberg.
Fig. 2. Transmission electron microscopic image of a cell infected with VACV
showing IVs forming within a virus factory. Free ends, lipoprotein membrane and
D13 scaffold are labeled with arrows. Scale bar at bottom. Provided by A. Weisberg.
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1995). The target of brefeldin A is the guanine nucleotide exchange
factor (GBF1) (Donaldson et al., 1992; Helms and Rothman, 1992).
Inhibition of GBF1 induces the retrograde transport of proteins
from Golgi membranes to the ER and collapse of the Golgi
apparatus (Lippincott-Schwartz et al., 1989). Therefore, the bre-
feldin A study does not discriminate between roles of the ER,
ERGIC or Golgi network in VACV IV formation. In contrast, Sar1
GTPase is an essential component of coatomer protein II (COPII)-
mediated cargo transport from the ER to the ERGIC and other post-
ER compartments (Aridor et al., 2001; Kuge et al., 1994). Over-
expression of a dominant negative Sar1 protein had no effect on
formation of VACV IVs and MVs but like brefeldin A blocked
wrapping of MVs by Golgi membranes (Husain and Moss, 2003).
The Sar1 protein inhibitor result indicates that transport of viral
proteins from the ER to the ERGIC or beyond is unnecessary for
formation of IV and MV membranes, whereas such transport is
necessary for the subsequent addition of the wrapping membrane.
The drug H-89, a serine/threonine protein kinase inhibitor that
prevents assembly of Sar1 protein into the ER membrane, and
cerulenin, an inhibitor of lipid biogenesis, prevented infectious
virus formation following attempted reversal of an early morpho-
genesis block (Punjabi and Traktman, 2005). However, the stage at
which morphogenesis is affected by these drugs was not described
and H-89 may have multiple protein kinase targets.
Although the dominant negative Sar1 protein experiment shows
that transport from ER to post-ER compartments is unnecessary for
IV formation (Husain and Moss, 2003), they do not prove that the ER
itself is needed. An important next experiment would have been to
determine the effect of blocking import of proteins to the ER.
Unfortunately, neither a speciﬁc drug nor a potent dominant
negative inhibitor of this step is available for animal cells. An
alternative approach is to determine whether proteins could trafﬁc
to viral membranes through the ER. Since IV and MV proteins lack
cleaved signal peptides, one strategy was to attach a signal peptide
followed by a Flag epitope tag to the N-terminus of the viral A9
protein, which localizes in ER and IV membranes with the same
topology (Husain et al., 2006). Cleavage of the signal peptide would
put the Flag tag at the N-terminus and recognizable by a speciﬁc
monoclonal antibody. Since signal peptidase is associated with the
ER membrane, detection of the N-terminal Flag tag in IV membranes
provided evidence for trafﬁcking of the chimeric A9 protein through
the ER to the viral membrane (Husain et al., 2006). Furthermore,
addition of a COPII binding site to the A9 protein diverted it from
viral to Golgi membranes also providing evidence of a functional ER
connection (Husain et al., 2006). Additional experiments indicate
that transit to the viral membrane might be a default pathway for
proteins that are synthesized without a COPII signal in the virus
factory (Husain et al., 2007).
The major membrane proteins of crescents and IVs
The two major transmembrane protein components of VACV
crescents and IVs, A17 and A14, are expressed late in infection.
Both proteins are co-translationally inserted into microsomal
membranes in vitro and can be detected by immunoelectron
microscopy on ER and ERGIC membranes in addition to crescents
and IVs in vivo (Betakova and Moss, 2000; Krijnse-Locker et al.,
1996; Rodriguez et al., 1997; Unger et al., 2013; Wolffe et al., 1996).
Disulﬁde-bonded dimers of A14 interact with A17 directly or
indirectly and both proteins are phosphorylated by the F10 kinase
(Betakova et al., 1999b; Mercer and Traktman, 2003; Rodriguez
et al., 1997; Szajner et al., 2004; Unger et al., 2013). In vitro studies
suggest that the N- and C-termini of A17 face the cytoplasm
(Betakova and Moss, 2000; Betakova et al., 1999a; Krijnse-Locker
et al., 1996), whereas those of A14 may be luminal (Mercer and
Traktman, 2003; Salmons et al., 1997) although the precise
topologies of both proteins on IVs needs further investigation. In
addition, the N- and C-termini of A17 are trimmed by the I7
proteinase (Ansarah-Sobrinho and Moss, 2004; Betakova et al.,
1999b; Rodriguez et al., 1993; Takahashi et al., 1994). The N-
terminus of A17 is required for IV formation and interacts with
D13 trimers, which form the external honeycomb lattice (Bisht
et al., 2009; Heuser, 2005; Szajner et al., 2005; Unger et al., 2013).
Conditional lethal mutants have been employed to investigate the
stage at which A17 and A14 participate in viral membrane formation.
When expression of A17 is repressed, morphogenesis is blocked at an
early stage with small vesicles or tubules accumulating adjacent to
large, dense bodies of viroplasm (Rodríguez et al., 1996; Wolffe et al.,
1996). Small vesicles as well as empty crescents and incomplete IVs
also accumulate when A14 is repressed (Rodriguez et al., 1998;
Traktman et al., 2000). It is uncertain whether the empty crescents
and partial IVs represent leaky repression or the true null phenotype.
At the restrictive temperature, morphogenesis of temperature-sensitive
mutants of the F10 kinase (Lin and Broyles, 1994), which phosphor-
ylates A17 (Betakova et al., 1999b; Derrien et al., 1999) and A14
(Betakova et al., 1999b), is blocked prior to formation of small vesicles
suggesting that F10 might have additional targets (Traktman et al.,
1995;Wang and Shuman,1995). A similar, but less stringent phenotype
occurs when expression of F10 is repressed at 37 1C; raising the
temperature increased the stringency suggesting that some target of
the kinase may be temperature sensitive in the absence of phosphor-
ylation (Punjabi and Traktman, 2005; Szajner et al., 2004). Rescue of
the F10mutant in trans depends on an intact active kinase site (Punjabi
and Traktman, 2005; Szajner et al., 2004).
Rifampicin and the D13 scaffold protein
The antibiotic rifampicin, an inhibitor of prokaryotic DNA-
dependent RNA polymerase, has an unrelated anti-poxviral activity.
In the presence of the drug, irregular sheets of membrane form
adjacent to masses of viroplasm that contain the core proteins
(Grimley et al., 1970; Moss et al., 1969; Nagayama et al., 1970).
Washout of the drug leads to rapid coating of the membrane with
the spicule layer even if protein synthesis is inhibited (Moss et al.,
1969). The ﬁnding that rifampicin-resistant mutants map to the D13
protein suggested that the latter was a component of the spicule layer
(Baldick and Moss, 1987; Charity et al., 2007; Tartaglia et al., 1986).
Indeed, the effect of repression of D13 expression is identical to that of
Table 1
VMAPs.
Protein kDa Expression Interaction ERa Reference
A6 43 Post-rep A11 Meng et al. (2007), Meng et al. (2012)
A11 36 Post-rep A6, A32 þ Resch et al. (2005), Maruri-Avidal et al. (2013b), Wu et al. (2012)
A30.5 4.8 Post-rep L2 þ Maruri-Avidal et al. (2013c)
H7 17 Post-rep Satheshkumar et al. (2009), Meng et al. (2013)
L2 10 Pre-rep A30.5 þ Maruri-Avidal et al. (2011a,b), Maruri-Avidal et al. (2013a)
a Association with ER determined by immunoﬂuorescence confocal microscopy.
B. Moss / Virology 479-480 (2015) 619–626 621
rifampicin (Zhang and Moss, 1992). In the presence of rifampicin, D13
accumulates in separate inclusions (Sodeik et al., 1994). Subsequent
studies demonstrated that the so-called spicule layer is a honeycomb
lattice comprised of trimers of D13 (Heuser, 2005; Szajner et al.,
2005). D13 has no transmembrane domain and associates with the
viral membrane through interaction with the N-terminus of A17
(Bisht et al., 2009; Unger et al., 2013). This interaction is supported by
a recent ﬁnding that duplication or over expression of A17 confers
resistance to rifampicin (Erlandson et al., 2014). The removal of D13
trimers during the transition from IV to MV is associated with
processing of A17 (Bisht et al., 2009).
The structure of the D13 trimer was determined by cryoelec-
tron tomography (Hyun et al., 2007) and X-ray crystallography
(Bahar et al., 2011; Hyun et al., 2011). The analyses reveal a double
β-barrel “jelly-roll” subunit arranged as pseudo-hexagonal trimers
with similarity to the capsid proteins of icosahedral viruses. Most
mutations in D13 that confer resistance to rifampicin map in
contiguous membrane proximal regions. However, the binding site
for rifampicin has not yet been determined.
Viral membrane assembly proteins (VMAPs [pronounced
VeeMAPs])
A group of viral proteins that are involved in related steps in
formation of the IV membrane have been termed VMAPs (Maruri-
Avidal et al., 2013c). The VMAPs identiﬁed to date are the A6, A11,
A30.5, H7 and L2 proteins (Table 1), which are conserved in all
chordopoxviruses. Except for L2, the VMAPs are expressed exclusively
following genome replication. Three VMAPs (L2, A30.5 and A11) have
hydrophobic domains near their C-termini enabling association with
ER and viral membranes. Properties of individual VMAPs are pre-
sented below and their roles, determined by construction of mutant
viruses, are discussed in the subsequent section.
L2, a small 10-kDa protein with two near C-terminal hydrophobic
domains, is ﬁrst expressed early during infection (Maruri-Avidal et
al., 2011a). L2 colocalizes with the ER throughout the cytoplasm of
both infected and uninfected cells with the N-terminus exposed to
the cytoplasm (Maruri-Avidal et al., 2011b; Hyun, S., Maruri-Avidal,
L., and Moss, B., unpublished). Although small amounts are detected
in puriﬁed MVs (Maruri-Avidal et al., 2011b), immunoelectron
microscopy shows that the L2 within virus factories is
predominantly at the edges of crescents and nearby tubular mem-
branes containing ER markers (Maruri-Avidal et al., 2011a).
A30.5 is a 42-amino acid, largely hydrophobic protein that is
expressed post-replicatively and immunopuriﬁes with and cross-
links to L2 (Maruri-Avidal et al., 2013c). An ORF encoding a simi-
lar size hydrophobic protein is conserved in the same genomic
location in all chordopoxviruses, although the small size and
predominance of hydrophobic amino acids preclude statistical
conﬁrmation of homology. A30.5 colocalizes with the ER in both
infected and uninfected cells and in the former is also associated
with L2 and the edges of crescents and nearby ER membranes.
A11 is a 40-kDa protein, with two hydrophobic domains near the
C-terminus, conserved in all poxviruses. A11 was ﬁrst described as
interacting with itself and with the A32 DNA packaging protein in a
VACV genome-wide yeast two-hybrid screen (McCraith et al., 2000).
Although the interaction of A11 with A32 was conﬁrmed by
immunoprecipitation (Resch et al., 2005), the biological signiﬁcance
is unknown. Further studies indicate that A11 is expressed post-
replicatively, localizes in viral factories, and is absent from puriﬁed
virions (Resch et al., 2005). A11 weakly associates with A6, an
interaction that is necessary for membrane and virus factory
association of A11 (Wu et al., 2012). ER colocalization occurs only
within virus factories, in contrast to L2 and A30.5, which associate
with ER throughout the cell (Maruri-Avidal et al., 2013b). In unin-
fected cells A11 is broadly distributed in the cytoplasm and does not
colocalize with ER even if A6 or H7 are co-transfected, although A11
post-translationally associates with microsomes in a cell-free expres-
sion system (Maruri-Avidal et al., 2013b).
A6 is a 43-kDa protein, with no predicted transmembrane domain,
that is conserved in all chordopoxviruses, expressed post-replicatively
and to a minor extent packaged in MV cores (Meng et al., 2007). As
mentioned above, A6 has been shown to associate with the A11
protein (Wu et al., 2012).
H7 is a 40-kDa protein, with no predicted transmembrane
domain, that is conserved in all chordopoxviruses and expressed
post-replicatively (Satheshkumar et al., 2009). H7 is not detected
in highly puriﬁed MVs and is not strongly retained in viral
factories following synthesis (Satheshkumar et al., 2009). The
crystal structure of H7 reveals a novel fold comprised of seven
α-helices and a highly curved three-stranded antiparallel β-sheet
(Kolli et al., 2014). A basic patch representing a phosphoinositide-
binding site is essential for binding to phosphatidylinositol-3- and
4-phosphate in vitro (Kolli et al., 2014).
Fig. 3. Transmission electron microscopic images of a BS-C-1 cell infected with a VACV L2 deletion mutant showing dense inclusions. Arrows point to short crescents. V,
dense inclusion of viroplasm. Inset, high magniﬁcation of portion of inclusion. Scale bars shown. Adapted from Maruri-Avidal et al. (2013a).
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Fig. 4. Transmission electron microscopic images of cells infected with a VACV L2 and A30.5 deletion mutants showing association of ER and IV-like structures. (A and B)
VACV L2 deletion mutant infection of BS-C-1 cells. (C–F) VACV A30.5 deletion mutant infection of RK-13 cells. Arrows, membrane with spicule layer; Arrowheads, smooth
membrane. Scale bars shown. Adapted from Maruri-Avidal et al. (2013c).
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Analysis of conditional lethal VMAP mutants
The roles of individual VMAPs have been investigated primarily
by making conditional lethal inducible and/or deletion mutants. L2,
A30.5 and A11 null mutants have similar if not identical phenotypes.
Initial studies with an inducible L2 mutant demonstrated that
expression of the protein is required for virion assembly (Maruri-
Avidal et al., 2011a, 2011b). Large masses of dense viroplasm
containing core proteins or their precursors, some of which have
short, spicule-coated membrane arcs at their periphery that appear
to represent the beginning of crescent formation, form in the
absence of inducer. Although no typical IVs or MVs are seen, IV-
like structures devoid of internal dense material appear in close
association with ER membranes. In order to determine whether the
aberrant structures represent incomplete repression of L2 synthesis,
a L2 deletion mutant that could replicate in a stably transfected L2
cell line was constructed (Maruri-Avidal et al., 2013a). The phenotype
of the deletion mutant is identical to that of the inducible mutant.
Fig. 3 contains an image of a cell infected with the L2 deletion
mutant showing a dense inclusion with short crescent-like arcs on
the surface; Fig. 4A shows a cluster of IV-like structures surrounded
by a smooth membrane, as well as separate inclusions of dense
viroplasm. The external spicule layers of the IV-like structures as well
as connections with the smooth membrane are resolved at high
magniﬁcation (Fig. 4B). Similar strategies were used to construct and
analyze an A11 inducible mutant (Maruri-Avidal et al., 2013b; Resch
et al., 2005) and an A30.5 deletion mutant (Maruri-Avidal et al.,
2013c), both of which have the same phenotype as the L2 deletion
mutant. Immunoelectron microscopy demonstrated the presence of
A17, A14 and D13 in the crescent- and IV-like membranes and
calnexin, an ER marker in the associated smooth membranes
(Maruri-Avidal et al., 2013a, 2013c). Images of cells infected with
the A30.5 deletion mutant are shown in Fig. 4C–F. In Fig. 4C, the
membrane surrounding the cluster of IV-like structures appears
continuous with the external nuclear membrane, which connects
with the ER. Fig. 4D and E shows a single and multiple IV-like
particles within the ER lumen, respectively. Clear connections
between spicule-coated crescent membranes and the smooth mem-
branes are revealed in Fig. 4E and F and have been conﬁrmed by
tomography (Weisberg, A., Hansen, B.T., Hoyt, F.H., Maruri-Avidal, L.,
Moss, B., and Fischer, E.R., unpublished). The convex surfaces of the
crescents face the lumen so that the IVs pinch off into the expanded
luminal space. Discontinuities in the ER membrane apparently allow
access of D13 but not dense viroplasm into the lumen. For reasons
that are not yet understood, the IV-like structures are more abundant
in RK-13 cells than in BS-C-1 and HeLa cells.
Dense cytoplasmic inclusions some of which had short mem-
brane arcs similar to that shown in Fig. 3 instead of IVs and MVs
were found in cells infected with conditional lethal inducible A6
(Meng et al., 2012) and H7 (Satheshkumar et al., 2009) mutants.
The phenotype of an H7 deletion mutant appeared to be more
stringent as the dense inclusions lacked the short membrane arcs
(Meng et al., 2013). The presence of IV-like structures similar to
those in cells infected with L2, A30.5 and A11 have not been
reported for either A6 or H7 mutants.
The VMAP mutants exhibit additional defects that seem to be
secondary to the block in viral membrane formation and therefore
will only be mentioned here. These include destabilization of
certain membrane proteins including those that form the entry–
fusion complex and mislocalization and glycosylation of others
(Meng et al., 2007, 2012; Resch et al., 2005; Maruri-Avidal et al.,
2011a, 2011b, 2013a, 2013c; Satheshkumar et al., 2009).
A model for poxvirus membrane biogenesis
Electron micrographs from cells infected with VMAP null mutants
are the ﬁrst to demonstrate a direct connection between poxviral
membranes and ER. The model for viral membrane formation
depicted in Fig. 5 is based on the premise that a step in the normal
viral membrane biogenesis pathway has been interrupted revea-
ling ER connections. This hypothesis is supported by the identical
phenotype of three different null mutants. The model posits that
during a WT virus infection the L2, A30.5, A11, H7 and A6 VMAPs
participate with cellular proteins to produce interruptions or stabilize
naturally occurring transient breaks in a subsection of ER within the
virus factory. As shown by immunoelectron microscopy, the L2, A30.5
and A11 VMAPs cap the free ends of membrane segments containing
A17 and A14, which elongate by fusion with additional ER membrane
segments to form crescents and spherical IVs. The model suggests
that fragmentation of the ER membrane precedes crescent formation
making it difﬁcult or impossible to see ER connections during
infection with WT virus. In contrast, the ER membranes containing
A17 and A14 remain largely intact when L2, A30.5 or A11 is not
synthesized. In cells infected with the VMAP null mutants, occasional
breaks in the ER membrane allow the association of D13 with the N-
terminus of A17, which is on the luminal side of the ER. The curvature
imposed by D13 and A17, leads to the formation of IV-like spheres
that pinch off and collect in the modiﬁed ER lumen. The sequestration
of viral membranes in the lumen prevents their interaction with core
proteins, which aggregate into masses of dense viroplasm mostly
unadorned by viral membranes. A novel prediction of the model is
that the outer surface of the IV and MV represents the luminal side of
the ER. This topology can explain the exposure of some phosphati-
dylserine, which is more abundant on the luminal side of the ER
(Dominski et al., 1983; Fairn et al., 2011) on the surface of the MV
(Cluett and Machamer, 1996; Mercer and Helenius, 2008).
The above model represents a starting point for further research.
An important question is how breaks occur in the ER membrane.
One possibility is that the ER is constantly being remodeled but that
the breaks are rapidly sealed in uninfected cells. In this scenario, the
main role of the VMAPs may be to cap the ends of the membrane
fragments and prevent resealing. Alternatively, the VMAPs may
actively induce breaks perhaps in association with cell proteins.
Additional work is needed to deﬁne the roles of individual VMAPs,
particularly those that do not exhibit direct membrane binding. The
prediction that the surface of the IV represents the luminal side of
the ER was unanticipated and needs to be conﬁrmed for infection
Fig. 5. Model for formation of viral membranes during infection with wild-type
(WT) and mutant VACV. L2, A30.5, A11, A17, A14 and D13 refer to VACV proteins;
ΔL2, ΔA30.5 and ΔA11 refer to VACV deletion mutants. Adapted from Maruri-
Avidal et al. (2013c).
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with wild-type virus. This “inside-outside” topology raises questions
regarding the orientations of A17 and A14 and suggests that ER
breakage may precede the insertion of the major viral proteins.
Although the novel viral membrane-ER connections were demon-
strated with null mutants of three different viral proteins, putative
cell proteins involved need to be identiﬁed.
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